BRIDGEWAY CAPITAL MANAGEMENT, LLC

Position in SEER — Seer, Inc.

CIK 1107261 HOUSTON, TX

Position in SEER

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$771,864

-$343,416 QoQ

Shares Held

459,443

-24.6% QoQ

Ownership

0.836%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $59,315,164 across 112 Biotechnology names. SEER ranks #13 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GLUE	Monte Rosa Therapeutics, Inc.	528,698	$8,697,082
2	PBYI	Puma Biotechnology, Inc.	775,341	$4,954,428
3	EXEL	Exelixis, Inc.	66,100	$2,835,029
4	KROS	Keros Therapeutics, Inc.	195,017	$2,152,987
5	SGMT	Sagimet Biosciences Inc.	299,641	$1,565,624
6	BDTX	Black Diamond Therapeutics, Inc.	723,477	$1,541,006
7	PTCT	Ptc Therapeutics, Inc.	22,000	$1,498,860
8	KYTX	Kyverna Therapeutics, Inc.	149,900	$1,293,637

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$771,864	459,443	-24.6%	Shares	Sole	2026-05-15
2025-12-31	$1,115,280	609,443	-17.4%	Shares	Sole	2026-02-17
2025-09-30	$1,600,251	737,443	-11.9%	Shares	Sole	2025-11-14
2025-06-30	$1,792,128	837,443	+15.5%	Shares	Sole	2025-08-14
2025-03-31	$1,225,829	725,343	-0.3%	Shares	Sole	2025-05-15
2024-12-31	$1,681,086	727,743	+17.6%	Shares	Sole	2025-02-14
2024-09-30	$1,218,923	618,743	+55.1%	Shares	Sole	2024-11-14
2024-06-30	$670,392	399,043	+13.4%	Shares	Sole	2024-08-14
2024-03-31	$668,691	351,943	-13.1%	Shares	Sole	2024-05-15
2023-12-31	$785,977	405,143	+292.6%	Shares	Sole	2024-02-14
2023-09-30	$228,072	103,200	-22.5%	Shares	Sole	2023-11-14
2023-06-30	$568,764	133,200	—	Shares	Sole	2023-08-14
No filing history on record for this holder in this stock.